Gene · 9682
Papers1,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling. | Front Mol Biosci | 2022 | 35187083 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Ferroptosis-Associated Genes and Its Implication in Cancer Therapy. | Front Oncol | 2022 | 35174081 | PubTator, text mining | PubMed |
| Immediate-Early, Early, and Late Responses to DNA Double Stranded Breaks. | Front Genet | 2022 | 35173769 | PubTator, text mining | PubMed |
| Epigenetic Modification of PD-1/PD-L1-Mediated Cancer Immunotherapy against Melanoma. | Int J Mol Sci | 2022 | 35163049 | PubTator, text mining | PubMed |
| P53: Stability from the Ubiquitin-Proteasome System and Specific 26S Proteasome Inhibitors. | ACS Omega | 2022 | 35155881 | PubTator, text mining | PubMed |
| TRIM14 inhibits OPTN-mediated autophagic degradation of KDM4D to epigenetically regulate inflammation. | Proc Natl Acad Sci U S A | 2022 | 35145029 | PubTator, text mining | PubMed |
| Common genetic aspects between COVID-19 and sarcoidosis: A network-based approach using gene expression data. | Biochem Biophys Rep | 2022 | 35128085 | PubTator, text mining | PubMed |
| Aberrant miR-362-3p is Associated with EBV-Infection and Prognosis in Nasopharyngeal Carcinoma and Involved in Tumor Progression by Targeting JMJD2A. | Onco Targets Ther | 2022 | 35115787 | PubTator, text mining | PubMed |
| Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. | Int J Cancer | 2022 | 35076935 | PubTator, text mining | PubMed |
| Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents. | Cancer Control | 2022 | 35067084 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines. | Life (Basel) | 2022 | 35054489 | PubTator, text mining | PubMed |
| Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology. | Cells | 2022 | 35053315 | PubTator, text mining | PubMed |
| Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. | Cancer Treat Rev | 2022 | 35051883 | PubTator, text mining | PubMed |
| JMJD2C-mediated long non-coding RNA MALAT1/microRNA-503-5p/SEPT2 axis worsens non-small cell lung cancer. | Cell Death Dis | 2022 | 35046387 | PubTator, text mining | PubMed |
| Lead exposure induces dysregulation of constitutive heterochromatin hallmarks in live cells. | Curr Res Toxicol | 2022 | 35005634 | PubTator, text mining | PubMed |
| Downregulation of JMJD2a and LSD1 is involved in CK2 inhibition-mediated cellular senescence through the p53-SUV39h1 pathway. | BMB Rep | 2022 | 35000672 | PubTator, text mining | PubMed |
| Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells. | Chem Biol Interact | 2022 | 34999051 | PubTator, text mining | PubMed |
| Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity. | PLoS One | 2022 | 34986150 | PubTator, text mining | PubMed |
| miR‑30a‑5p induces the adipogenic differentiation of bone marrow mesenchymal stem cells by targeting FAM13A/Wnt/β‑catenin signaling in aplastic anemia. | Mol Med Rep | 2022 | 34821370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9682/papers?page=24